Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways.
Santana FPR, da Silva RC, Ponci V, Pinheiro AJMCR, Olivo CR, Caperuto LC, Arantes-Costa FM, Claudio SR, Ribeiro DA, Tibério IFLC, Lima-Neto LG, Lago JHG, Prado CM.
Santana FPR, et al. Among authors: ponci v.
Biochem Pharmacol. 2020 Oct;180:114175. doi: 10.1016/j.bcp.2020.114175. Epub 2020 Jul 24.
Biochem Pharmacol. 2020.
PMID: 32717226
Free article.